(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 1228950
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 93.94 | 96.28 | 96.38 | 92.56 | 1.026 times |
| 13 Thu Feb 2025 | 95.19 | 95.00 | 100.82 | 94.71 | 2.217 times |
| 12 Wed Feb 2025 | 103.56 | 99.33 | 104.92 | 99.08 | 0.934 times |
| 11 Tue Feb 2025 | 101.57 | 103.01 | 104.09 | 100.72 | 0.794 times |
| 10 Mon Feb 2025 | 104.00 | 105.15 | 105.15 | 100.76 | 1.498 times |
| 07 Fri Feb 2025 | 104.98 | 109.43 | 110.55 | 103.98 | 1.016 times |
| 06 Thu Feb 2025 | 109.62 | 110.37 | 112.00 | 108.84 | 0.781 times |
| 05 Wed Feb 2025 | 110.37 | 113.55 | 115.77 | 110.17 | 0.951 times |
| 04 Tue Feb 2025 | 113.40 | 110.61 | 114.14 | 110.61 | 0.721 times |
| 03 Mon Feb 2025 | 111.50 | 109.20 | 112.70 | 109.06 | 0.616 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 95.3, for a target of 102.8 or 109.05
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 85.91 |
| Downside Target | 92.56 |
| Upside Target | 94.98 |
| Upside Target | 98.41 |
| Upside Target | 103.55 |
| Upside Target | 108.16 |
| Upside Target | 112.18 |
| Upside Target | 115.77 |
| Upside Target | 117.48 |
| Upside Target | 118.25 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 89.28 |
| Downside Intraday Target | 84.63 |
| Upside Intraday Target | 101.87 |
| Upside Intraday Target | 109.81 |
| Upside Intraday Target | 97.22 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 93.94 | 105.15 | 105.15 | 92.56 | 1.583 times |
| 07 Fri Feb 2025 | 104.98 | 109.20 | 115.77 | 103.98 | 1.327 times |
| 31 Fri Jan 2025 | 112.53 | 113.90 | 118.25 | 112.18 | 1.027 times |
| 24 Fri Jan 2025 | 114.91 | 110.24 | 117.48 | 108.16 | 3.792 times |
| 17 Fri Jan 2025 | 110.05 | 105.87 | 110.28 | 104.73 | 0.15 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 93.94 | 109.20 | 115.77 | 92.56 | 0.64 times |
| 31 Fri Jan 2025 | 112.53 | 88.06 | 118.25 | 86.72 | 1.977 times |
| 31 Tue Dec 2024 | 87.22 | 96.29 | 98.41 | 85.91 | 0.829 times |
| 26 Tue Nov 2024 | 94.63 | 87.53 | 103.55 | 87.28 | 0.85 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 103.12 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 103.12 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.